IDA & IBRD total vs Tajikistan: Immunization, Hib3
IDA & IBRD total
75.9%
in 2024
Tajikistan
97.0%
in 2024
IDA & IBRD total rank
28th
Tajikistan rank
29th
Immunization, Hib3 over time
- IDA & IBRD total
- Tajikistan
How they compare
Tajikistan currently reports 97.0% against 75.9% in IDA & IBRD total, a difference of 21.1%.
That makes Tajikistan's figure about 1.3 times IDA & IBRD total's.
Across all 17 years both countries report, Tajikistan has been ahead every year.
IDA & IBRD total ranks 28th and Tajikistan ranks 29th of 43 groups.
Tajikistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA & IBRD total | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.0% | 69.5% | 41.5% | Tajikistan |
| 2010s | 54.7% | 95.9% | 41.2% | Tajikistan |
| 2020s | 72.6% | 96.8% | 24.2% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, IDA & IBRD total or Tajikistan?
- Tajikistan, at 97.0% against 75.9% in IDA & IBRD total as of 2024.
- What is the difference in immunization, hib3 between IDA & IBRD total and Tajikistan?
- 21.1%, with Tajikistan ahead.
- How many years of comparable data are there for IDA & IBRD total and Tajikistan?
- 17 years are reported by both, from 2008 to 2024.
- How do IDA & IBRD total and Tajikistan rank globally for immunization, hib3?
- IDA & IBRD total ranks 28th and Tajikistan ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.